Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease.

Orskov B, Christensen KB, Feldt-Rasmussen B, Strandgaard S.

Kidney Int. 2012 May;81(9):919-24. doi: 10.1038/ki.2011.459. Epub 2012 Feb 1.

2.

Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark.

Orskov B, Rømming Sørensen V, Feldt-Rasmussen B, Strandgaard S.

Clin J Am Soc Nephrol. 2010 Nov;5(11):2034-9. doi: 10.2215/CJN.01460210. Epub 2010 Jul 29.

4.
5.

Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease.

Helal I, McFann K, Reed B, Yan XD, Schrier RW, Fick-Brosnahan GM.

Nephrol Dial Transplant. 2013 Feb;28(2):380-5. doi: 10.1093/ndt/gfs417. Epub 2012 Dec 4.

6.

Anticipation of end stage renal disease in patients with autosomal dominant polycystic kidney disease in successive generations.

Sotirakopoulos N, Tsitsios T, Stambolidou M, Cristodoulidou C, Spaia S, Mavromatidis K.

Ren Fail. 2001 Sep;23(5):715-20.

PMID:
11725918
7.

Effects of endothelial nitric oxide synthase gene on end stage renal disease progression in autosomal dominant polycystic kidney disease.

Xue C, Zhou CC, Sun LJ, He LL, Xu CG, Dai B, Mei CL.

Nephrology (Carlton). 2014 Oct;19(10):630-7. doi: 10.1111/nep.12310. Review.

PMID:
24995932
8.

Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.

Magistroni R, He N, Wang K, Andrew R, Johnson A, Gabow P, Dicks E, Parfrey P, Torra R, San-Millan JL, Coto E, Van Dijk M, Breuning M, Peters D, Bogdanova N, Ligabue G, Albertazzi A, Hateboer N, Demetriou K, Pierides A, Deltas C, St George-Hyslop P, Ravine D, Pei Y.

J Am Soc Nephrol. 2003 May;14(5):1164-74.

9.

Racial variation in autosomal dominant polycystic kidney disease.

Freedman BI, Soucie JM, Chapman A, Krisher J, McClellan WM.

Am J Kidney Dis. 2000 Jan;35(1):35-9.

PMID:
10620541
10.

The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.

Cornec-Le Gall E, Audrézet MP, Rousseau A, Hourmant M, Renaudineau E, Charasse C, Morin MP, Moal MC, Dantal J, Wehbe B, Perrichot R, Frouget T, Vigneau C, Potier J, Jousset P, Guillodo MP, Siohan P, Terki N, Sawadogo T, Legrand D, Menoyo-Calonge V, Benarbia S, Besnier D, Longuet H, Férec C, Le Meur Y.

J Am Soc Nephrol. 2016 Mar;27(3):942-51. doi: 10.1681/ASN.2015010016. Epub 2015 Jul 6.

11.

Analysis of baseline parameters in the HALT polycystic kidney disease trials.

Torres VE, Chapman AB, Perrone RD, Bae KT, Abebe KZ, Bost JE, Miskulin DC, Steinman TI, Braun WE, Winklhofer FT, Hogan MC, Oskoui FR, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin DR, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Meyers CM, Schrier RW; HALT PKD Study Group.

Kidney Int. 2012 Mar;81(6):577-85. doi: 10.1038/ki.2011.411. Epub 2011 Dec 28.

12.

Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease.

Magistroni R, Manfredini P, Furci L, Ligabue G, Martino C, Leonelli M, Scapoli C, Albertazzi A.

J Nephrol. 2003 Jan-Feb;16(1):110-5.

PMID:
12653106
13.

Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease.

Paterson AD, Magistroni R, He N, Wang K, Johnson A, Fain PR, Dicks E, Parfrey P, St George-Hyslop P, Pei Y.

J Am Soc Nephrol. 2005 Mar;16(3):755-62. Epub 2005 Jan 26.

14.

Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease.

Reiterová J, Merta M, Stekrová J, Cabartová Z, Cibulka R, Maixnerová D, Rysavá R, Ríhová Z, Tesar V, Motán J.

Kidney Blood Press Res. 2006;29(3):182-8. Epub 2006 Aug 30.

15.
16.

Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.

Reiterová J, Obeidová H, Lenícek M, Stekrová J, Merta M, Maixnerová D, Vítek L, Viklický O, Tesar V.

Kidney Blood Press Res. 2008;31(6):398-403. doi: 10.1159/000180269. Epub 2008 Dec 8.

17.

Variation in age at ESRD in autosomal dominant polycystic kidney disease.

Reed BY, McFann K, Bekheirnia MR, Nobakhthaghighi N, Masoumi A, Johnson AM, Shamshirsaz AA, Kelleher CL, Schrier RW.

Am J Kidney Dis. 2008 Feb;51(2):173-83. doi: 10.1053/j.ajkd.2007.10.037. Erratum in: Am J Kidney Dis. 2008 Jul;52(1):199. Reza Bekheirnia, M [corrected to Bekheirnia, Mir R]; Nobkhthaghighi, Niloofar [corrected to Nobakhthaghighi, Niloofar]; Shamshiraz, Alireza Abdollah [corrected to Shamshiraz, Alireza A].

18.

Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.

Dicks E, Ravani P, Langman D, Davidson WS, Pei Y, Parfrey PS.

Clin J Am Soc Nephrol. 2006 Jul;1(4):710-7. Epub 2006 Jun 8.

19.

Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease.

Pérez-Oller L, Torra R, Badenas C, Milà M, Darnell A.

Am J Kidney Dis. 1999 Aug;34(2):273-8.

PMID:
10430974
20.

Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.

Persu A, El-Khattabi O, Messiaen T, Pirson Y, Chauveau D, Devuyst O.

Nephrol Dial Transplant. 2003 Oct;18(10):2032-8.

PMID:
13679477

Supplemental Content

Support Center